Hong Kong
-
1
Shein Hong Kong IPO prices at $26.5bn valuation, set to raise $1.7bn
Multiple sources confirm Shein is pricing its Hong Kong IPO at mid-range, valuing the fast-fashion giant at US$26.5 billion and raising approximately US$1.7 billion. The pricing represents a significant discount to Shein's prior private valuation of ~$66 billion, reflecting sustained pressure from US-China trade tensions, tariff exposure on cross-border e-commerce, and lingering regulatory scrutiny. The deal is one of the largest HKEX listings in recent years and signals a potential revival of the Hong Kong IPO pipeline after an extended drought. Zhongji InnoLight's concurrent full exercise of its overallotment option (netting HK$7.9 billion) underscores improving institutional appetite for Hong Kong new issuance.
Why it matters: Shein's pricing clears a key uncertainty for HKEX IPO sentiment: a mid-range print on a high-profile deal validates the market's ability to absorb large listings and could unlock queued issuance from Chinese robotics, biotech, and tech firms, directly affecting HKEX fee revenue and Hang Seng float composition. The steep discount to prior private valuation is a cross-read on how public markets are pricing US tariff and regulatory risk into China-exposed consumer platforms.
-
2
HKEX explores merging GEM board with main board via new Chapter 18D
HKEX is considering abolishing the GEM small-cap board and absorbing it into the main board under a new Chapter 18D of listing rules, with a public consultation targeted by end-2026 as part of the second phase of its listing regime review. The move is designed to reboot a largely dormant market segment that has suffered from thin liquidity, low institutional participation, and reputational concerns around listing quality. If adopted, Chapter 18D could set differentiated financial thresholds for smaller or growth-stage issuers while maintaining main-board governance standards. The reform directly follows HKEX's Phase 1 changes that created specialist technology company and biotech chapters.
Why it matters: A successful GEM-main board merger would structurally expand HKEX's addressable issuer universe—particularly for Chinese robotics, AI, and biotech start-ups currently eyeing Hong Kong—improving HKEX's competitive positioning against Singapore and US listings; investors in HKEX (388 HK) should reassess medium-term listing fee and market-data revenue assumptions if the consultation advances on schedule.
-
3
Akeso's ivonescimab beats AstraZeneca's Imfinzi in phase 3 biliary tract cancer trial
Chinese biopharmaceutical firm Akeso announced that ivonescimab plus chemotherapy outperformed AstraZeneca's Imfinzi (durvalumab) plus chemotherapy in a head-to-head phase-3 trial for biliary tract cancer. Ivonescimab is a PD-1/VEGF bispecific antibody already licensed to US firm Summit Therapeutics in a multibillion-dollar deal. This is the second major head-to-head win for ivonescimab against a Western immunotherapy standard of care, adding to earlier data in lung cancer. The result expands ivonescimab's addressable indication set and strengthens Summit's ex-China commercialization thesis.
Why it matters: Successive head-to-head victories against Western blockbusters validate China biopharma's ability to compete globally on clinical endpoints, a consensus assumption that has been shifting; this cross-reads directly to Summit Therapeutics (SMMT US) licensing economics and raises competitive risk to AstraZeneca's Imfinzi franchise revenue in Asia and potentially globally.
-
4
Prudential reports 8% H1 new business profit growth, launches $300m buyback
Prudential plc reported an 8% increase in new business profit (NBP) for H1 2026, a deceleration from prior-year growth rates, alongside a US$300 million share buyback to be completed by December. Management flagged market concerns over a potential pullback in mainland Chinese visitors to Hong Kong, a critical driver of its HK-sold life insurance segment. The buyback signals capital confidence but the NBP growth slowdown will draw scrutiny given the high multiple the market assigns to Prudential's Asia franchise. HK/China insurance demand from mainland visitors has been a key growth pillar across the sector.
Why it matters: Prudential's slowing NBP is a leading indicator for the entire Hong Kong-listed insurer peer group (AIA, FWD) and tests the durability of the mainland-visitor insurance demand thesis; any sustained reduction in cross-border visitor insurance buying would require a meaningful downward revision to sector earnings growth assumptions for 2026-27.
-
5
China robotics IPO wave accelerates as two more Alibaba-backed firms target HKEX
Two Hangzhou-based embodied-AI robotics start-ups founded by former Alibaba executives—Infiforce Technology Group and an unnamed peer—have confirmed plans to list in Hong Kong as early as 2027, adding to a growing pipeline of Chinese robotics IPOs targeting HKEX. The announcements follow a broader wave of Chinese AI hardware and robotics companies choosing Hong Kong over US exchanges amid sustained export-control and delisting risk. HKEX's recently established specialist technology framework is cited as a key draw, alongside deep access to mainland and international institutional capital.
Why it matters: The accelerating robotics IPO pipeline is a structural positive for HKEX market depth and tech-sector weighting in the Hang Seng indices, creating index-inclusion flow implications; it also cross-reads to global industrial robotics competitive dynamics, as well-funded Chinese pure-plays listing publicly will accelerate R&D spend and commercialization timelines relative to Japanese and European incumbents.
Japan
-
1
BOJ Deputy Governor Himino Calls for Timely Rate Hikes, Flags Inflation Risk
BOJ Deputy Governor Ryozo Himino signaled that Japan may need 'timely' rate increases, emphasizing persistent inflation vigilance while stopping short of an explicit September hike commitment. Multiple sources confirm he stressed balancing economic data against inflation risks, keeping a September move firmly in play. The yen held near 159.00 and was largely unmoved by the remarks ahead of the Jackson Hole meeting and upcoming Tokyo CPI data. Japan's 2-year and 10-year bond yields both edged higher as markets repriced the rate path, with service inflation cited as a key supportive driver.
Why it matters: Himino's hawkish framing reinforces consensus that the BOJ tightening cycle is not paused — a September hike would further unwind JPY carry trades, pressuring global risk assets and EM positioning that relies on cheap yen funding; investors should monitor Friday's Tokyo CPI and Fed Chair Warsh's Jackson Hole remarks as the dual catalysts that could force near-term repositioning.
-
2
Japan Credit Unions Hit by Bond Losses as Long-End Yields Rise
Japanese credit unions are absorbing marked-to-market bond losses as long-term JGB yields climb in the wake of BOJ policy normalization. The stress is concentrated in smaller regional financial institutions that built up duration exposure during the zero-rate era and lack the hedging infrastructure of major banks. This mirrors a structurally familiar pattern — regional lenders squeezed by rate rises on existing portfolios while lending income lags. The development follows the government's active consideration of retail incentive programs to widen the JGB investor base as the BOJ reduces its own purchases.
Why it matters: Realized and unrealized bond losses at credit unions raise the risk of credit tightening in regional economies and signal that the transmission of BOJ normalization to financial stability stress points is accelerating — investors positioned in Japanese regional bank equities or holding assumptions of smooth JGB absorption need to revisit those theses.
-
3
Kioxia Plans Third Iwate Fab to Meet Surging AI NAND Memory Demand
Kioxia announced plans to build a third NAND flash memory fabrication facility at its Iwate Prefecture site, citing growing AI-driven memory demand. The expansion signals that AI workload growth is pulling through persistent capacity investment in NAND, a segment that has lagged HBM/DRAM in the memory recovery cycle. This follows Kioxia's recent Tokyo IPO and positions the company to compete with Samsung and SK Hynix as AI storage requirements scale. No capex figure was disclosed in the available snippet, but a third fab at an existing site implies significant incremental investment.
Why it matters: Kioxia's greenfield capacity decision is a direct read-through on AI infrastructure demand durability — confirming that hyperscaler and data-center build-out is pulling forward NAND capex alongside HBM, which supports the broader memory sector bull thesis and has cross-read implications for equipment suppliers (Tokyo Electron, Shin-Etsu) and Western Digital's joint-venture economics.
-
4
SoftBank in Talks to Acquire Majority Stake in Humanoid Startup 1X Technologies
SoftBank Group is reportedly in negotiations to take a majority stake in 1X Technologies, a humanoid robotics startup, according to GF Value/GuruFocus citing market reports. The deal, if completed, would mark SoftBank's most direct bet on humanoid robotics since its Pepper/Boston Dynamics era and underscores Masayoshi Son's renewed push into physical AI. GF Value simultaneously flagged SFTBY as 84.4% overvalued on its proprietary metric, highlighting the valuation tension between SoftBank's AI deal flow and its underlying NAV. No deal size was disclosed in the snippet.
Why it matters: A majority stake in a leading humanoid platform would shift SoftBank's portfolio exposure meaningfully toward physical AI, re-rating the M&A premium in the robotics supply chain (actuators, sensors, edge compute); it also signals that humanoid funding rounds are escalating to strategic majority deals rather than minority venture stakes, compressing the time horizon for commercialization bets.
-
5
Japan Studies Blockchain-Based Instant Settlement for Stocks and Government Bonds
Japanese authorities are advancing plans to study blockchain-enabled real-time settlement infrastructure for equities and JGBs, according to multiple reports citing government and regulatory sources. The initiative would overhaul Japan's existing T+2 settlement convention and could materially reduce counterparty and liquidity risk in JGB markets — particularly relevant as the BOJ reduces its balance sheet and secondary market liquidity becomes more critical. The study phase implies regulatory engagement with domestic exchanges (JPX) and custodians before any deployment. Timing for a live system remains unspecified.
Why it matters: If implemented, atomic settlement of JGBs would structurally reduce repo and collateral friction, altering how foreign investors and primary dealers manage duration exposure — it also establishes a regulatory precedent that cross-reads to broader Asia tokenization ambitions (Hong Kong, Singapore) and could attract incremental foreign participation in Japanese capital markets.
Korea
-
1
Bank of Korea hikes to 3.0%, second consecutive 25bp rise; signals further tightening
The Bank of Korea raised its benchmark rate by 25bp to 3.0% on Aug 27, marking the first back-to-back hike in the current cycle. Governor Shin framed the move as 'preemptive,' citing core inflation projected to stay above target 'for a considerable time,' and left the door open to additional hikes. The BOK simultaneously upgraded its 2026 GDP forecast to 3.3% — the strongest in five years — driven by semiconductor exports. The Korean won hit an 11-month high on the decision, while KOSPI pared an Nvidia-driven morning rally as the rate surprise absorbed risk appetite.
Why it matters: A consecutive hike cycle at 3.0% with an explicit upward-open guidance reprices the BOK reaction function — markets must now consider whether the terminal rate assumption needs to shift higher, pressuring duration in KRW bonds and raising the hurdle for equity re-rating. The won strength and widening rate differential vs. BoJ also has carry-trade implications for KRW/JPY positioning.
-
2
Activist fund targets Samsung Electronics in Korea's first shareholder rights rules test
An activist fund has taken aim at Samsung Electronics in what the Financial Times describes as the first live test of South Korea's new shareholder rights rules. The action follows recent corporate governance reform legislation that strengthens minority investor protections and director accountability. The specific demands and fund identity were not fully detailed in the snippet, but the framing as a 'first test' signals this is a precedent-setting case with broad implications for chaebol governance. Samsung separately announced it is considering appealing an £8.5m UK High Court ruling in a Swatch watch-face IP suit — a marginal earnings item but adding to headline risk.
Why it matters: Korea's governance reform trajectory is a key pillar of the 'Korea Discount' re-rating thesis driving global EM equity rotation into KOSPI; a high-profile activist success at Samsung would validate the reform framework and accelerate foreign institutional re-engagement, while a dismissal or procedural block would dampen the thesis.
-
3
Mirae Asset targets $109bn digital asset business via renamed Korbit exchange Digital X
Mirae Asset Financial Group founder Park Hyeon-joo outlined a 150 trillion won ($109bn) digital asset AUM target built around Digital X (formerly Korbit), in which Mirae Asset Consulting acquired a 97.15% stake in July. The ambition encompasses crypto and blockchain-based finance as a new group growth engine alongside Mirae's existing $282bn ETF platform — now ranked 11th globally and 2nd in Asia. The dual announcements in one session signal a deliberate strategic pivot into regulated digital assets at institutional scale. No timeline breakdown was given beyond the headline target.
Why it matters: A top-tier Korean financial group committing $109bn in digital asset AUM targets at an exchange it controls is a direct read on Asia institutional crypto adoption and regulatory confidence — cross-reading to global crypto-adjacent equities and stablecoin/virtual asset regulatory momentum; it also tests whether Korea's virtual asset framework (VASP regime) can support institutional-grade custody and product structuring at this scale.
-
4
Hyundai Motor targets 80% North American local sourcing, 10+ hybrid models by 2030 to offset tariffs
At its 2026 CEO Investor Day, Hyundai Motor announced it will raise North American local parts sourcing from a 60% to an 80% target by 2030 and expand its North American hybrid lineup to more than 10 models, with hybrids targeting roughly half of regional sales. The strategy is explicitly framed as a tariff mitigation response, shifting capex and supply chain commitments toward US-based production. This represents a material revision to prior guidance on regional manufacturing intensity and product mix, with implications for the Korean parts supply chain and for Hyundai's NA margin structure.
Why it matters: Raising the localization target by 20 percentage points directly reduces Hyundai's US tariff exposure but compresses Korean-origin parts demand — a negative read for Korean auto component suppliers (including Hyundai Mobis) while signaling that US tariff risk is now structurally embedded in Hyundai's long-term capex planning; the hybrid-over-EV pivot also aligns with global OEM trend data that investors should weigh against pure-EV supply chain exposures.
-
5
South Korea launches CPTPP consultation and plans chip-tax-windfall sovereign future fund
South Korea has formally launched a public consultation on joining CPTPP, simultaneously eyeing expanded trade ties with Central Asia and Africa — a structural trade diversification move that gains urgency against US tariff risk. Separately, the government announced plans to establish a sovereign future fund seeded by tax revenues from the semiconductor export boom, with a budget proposal including 600bn won allocated to humanoid robotics for 2027 as part of a 2.3tn won ($1.66bn) full-stack humanoid development program through 2030. These fiscal decisions are being signaled ahead of the formal 2027 budget announcement.
Why it matters: CPTPP accession would structurally alter Korea's export market access and tariff exposure across 12 economies, a multi-year positive for export-oriented industrials and semis; the chip-windfall sovereign fund and robotics budget commitment signal the government intends to recycle semiconductor revenue into next-generation industrial policy, creating investable capex flows in robotics, AI hardware, and advanced manufacturing.
India
-
1
RBI Shifts to Asymmetric Intervention, Defending Rupee on Every Dip
Bloomberg reports the Reserve Bank of India has adopted a strategy of intervening in FX markets whenever the rupee weakens, rather than managing two-way volatility. The rupee opened at ₹95.44 against the dollar on August 27, down 3 paise, with RBI activity cited as a key stabilising force. This marks a shift from the prior approach of allowing broader rupee fluctuation, suggesting the RBI has set an informal floor. The intervention posture comes despite falling crude oil prices (Brent at ~$87), which would ordinarily support the currency organically.
Why it matters: An asymmetric RBI intervention regime changes the risk-reward on INR carry trades and affects FII hedging costs; it also constrains the pace of FX reserve drawdown, which investors should monitor as a signal of macro stress tolerance. This is a direct consensus-assumption shift on rupee volatility.
-
2
India Equity Outlook Cut Again as Foreign Funds Rotate to Cheaper Asia
Foreign institutional investors are reducing India equity allocations for a second consecutive downgrade cycle, rotating to other Asian markets perceived as offering better value. This follows a period in which promoters and PE funds sold ₹58,000 crore of Indian equities in August alone, with PE exits running at five times the prior month's pace—the highest level since early 2026. Concurrently, Sensex and Nifty remain rangebound, with India VIX at a low 10.84, masking the supply overhang from the primary and secondary markets simultaneously absorbing capital.
Why it matters: A double downgrade of India's equity outlook by foreign funds, combined with record PE exit supply, directly challenges the consensus assumption of sustained FII inflows underpinning Indian equity multiples; investors should reassess near-term large-cap India long positions and monitor FII flow data closely.
-
3
Piramal Finance ₹2,100 Crore QIP Draws 10x Demand Led by BlackRock, Goldman
Piramal Finance's first QIP since listing attracted bids of approximately ₹21,000 crore against ₹2,100 crore on offer—a 10x oversubscription—with the issue priced at the top of the ₹2,000–2,110 range. BlackRock, Goldman Sachs Asset Management, and leading Indian domestic AMCs participated. The strong demand signals renewed global institutional appetite for Indian NBFC credit, a segment that has faced funding cost headwinds. This is a meaningful sentiment datapoint for the broader non-bank financial sector.
Why it matters: A 10x oversubscribed NBFC QIP anchored by global allocators shifts the assumption on NBFC funding access and institutional risk appetite for Indian credit; it is a cross-read for the broader financials sector re-rating and secondary market flows into NBFC equities.
-
4
Tata Power Loses $490 Million Singapore Arbitration on Russian Coal Asset
The Singapore International Commercial Court dismissed Tata Power's challenge to a $490 million arbitration award in favour of Kleros Capital Partners, relating to a Russian coal project dispute. Tata Power shares fell ~4% intraday to ₹348.20. The company has 28 days to file an appeal with the Singapore Court of Appeal, introducing further uncertainty. The liability, if crystallised, is material relative to the company's balance sheet and its ongoing capex commitments across renewables and power infrastructure.
Why it matters: A confirmed $490 million liability would pressure Tata Power's leverage metrics and potentially slow its renewable energy capex ramp—a key valuation driver; investors in India's power and clean-energy thematic need to reprice balance sheet risk for this name.
-
5
Lupin Downgraded to Sell by Citi; FY27 EPS Cut 14% on US Business Weakness
Citi downgraded Lupin to Sell and cut its target price to ₹2,050, reducing FY27 EPS estimates by 14%. The brokerage expects weaker US base-business sales, margin compression, and limited near-term new product contributions. Lupin shares fell ~2% on the news. This is the second notable cut to a large Indian pharma name's US business outlook in recent weeks, indicating that the US generics pricing environment is deteriorating more broadly than previously modelled.
Why it matters: A 14% EPS cut for a large-cap Indian pharma with significant US generics exposure is a sector-level read: investors with India pharma overweights should revisit US revenue assumptions across Sun Pharma, Dr. Reddy's and Cipla, as the headwind appears systemic rather than company-specific.
Asia Tech
-
1
SK Hynix Breaks Ground on $3.87B U.S. HBM Fab; Indiana Mass Production Targeted by 2028
SK Hynix held the groundbreaking ceremony for its $3.87 billion HBM manufacturing facility in Indiana, with mass production targeted for 2028. The plant is the first dedicated HBM fab on U.S. soil and directly serves Nvidia's accelerating procurement pipeline. This follows Nvidia's blockbuster quarterly results in which it reportedly more than doubled memory purchases, sending SK Hynix and Samsung shares sharply higher and pushing the KOSPI toward record highs. Bank of America simultaneously reiterated its bullish memory super-cycle thesis on SK Hynix, citing a shareholder returns target of 100 trillion won.
Why it matters: The groundbreaking locks in multi-year HBM supply alignment between SK Hynix and U.S. hyperscalers/Nvidia and de-risks the stock from export-control tail risk; combined with Nvidia's doubled memory spend, it validates the consensus assumption that HBM demand is structurally accelerating and raises the floor on SK Hynix and Samsung memory earnings estimates through 2028.
-
2
Kioxia Plans JPY 1T+ New NAND Fab in Japan; Operations Eyed for 2029 or Later
Kioxia is planning a new NAND flash fabrication facility in Japan with a capital commitment exceeding JPY 1 trillion (~$6.5B), according to Bloomberg and TrendForce, with operations targeted no earlier than 2029. The announcement drove Kioxia shares up 5.0%, topping the Nikkei 225 by turnover on August 27. The investment is framed as a response to surging AI-driven memory demand and comes as Chinese rival YMTC's NAND benchmark performance is reported to have closed within 1% of SK Hynix's DDR5 at 8,000 MT/s, raising competitive pressure on Japanese and Korean incumbents. Separately, YMTC's broader NAND market share rise is flagged by Korea Herald as a material structural threat to Samsung and SK Hynix in commodity NAND.
Why it matters: Kioxia's capex commitment signals a supply-side response to AI memory demand that will reshape NAND pricing dynamics by 2029; the concurrent YMTC/CXMT competitive data points are a cross-read for margin compression risk in commodity memory, which investors must weigh against the HBM super-cycle narrative for Samsung and SK Hynix.
-
3
SoftBank Eyes Majority Stake in OpenAI-Backed Humanoid Startup 1X at $6B Valuation
SoftBank Group is in advanced talks to acquire a majority stake in 1X Technologies, a Norwegian humanoid robotics startup backed by OpenAI, at an implied valuation of approximately $6 billion, according to The Information and corroborated by multiple outlets. The deal would mark SoftBank's most direct bet on physical AI/humanoid hardware, extending its AI investment posture beyond software (OpenAI, Arm) into embodied robotics. GF Value analysis flags SFTBY as trading at an 84.4% premium to intrinsic value even before this deal, suggesting the market is already pricing in significant option value. The move also signals competitive pressure from other robotics-focused capital allocators including Amazon and Hyundai.
Why it matters: A completed majority acquisition would materially increase SoftBank's concentration in pre-revenue, capital-intensive AI hardware bets, raising questions about Vision Fund 3 deployment discipline and cash burn; it also validates the humanoid robotics investment theme, providing a read-through valuation benchmark for comparable private and public robotics equities globally.
-
4
Coupang Blocks Korea FTC Raid, Files Lawsuit in Unprecedented Antitrust Confrontation
Coupang physically refused entry to Korea Fair Trade Commission investigators and simultaneously filed a lawsuit challenging the regulator's inspection authority — the first such case in Korean antitrust history, according to Seoul Economic Daily and Businesskorea. The FTC probe, which had been ongoing, stalled completely following the refusal, with watchdog officials unable to access company premises. South Korean lawmakers have separately subjected the Coupang CEO to aggressive parliamentary questioning, drawing international attention. The standoff materially escalates regulatory and legal risk for the company and introduces uncertainty over the investigation's scope and timing.
Why it matters: Coupang's unprecedented legal confrontation with the FTC resets the regulatory risk premium for the stock: a prolonged legal battle could delay or permanently impair any adverse FTC ruling but also signals deteriorating relations with Korean authorities, complicating Coupang's expansion plans and investor sentiment at a time when slowing customer growth and profitability concerns are already weighing on the thesis.
-
5
Flashlight Activist Fund Proposes $3.2B Buyout of Samsung Security Unit S-1 at 45% Premium
Activist fund Flashlight has proposed a $3.2 billion buyout of Samsung's security subsidiary S-1 Corporation, offering a 45% premium to the prevailing share price, according to Bloomberg and KED Global. The proposal targets what Flashlight characterizes as a deeply undervalued, cash-generative business sitting within Samsung's sprawling conglomerate structure. This represents the latest in a series of activist pressures on Samsung Group affiliates and comes at a time when Samsung Electronics itself faces intensifying HBM execution concerns and management scrutiny. A successful spin-out or buyout would crystallize NAV value and could set a precedent for further unlocking of Samsung Group subsidiaries.
Why it matters: The S-1 buyout proposal is an incremental catalyst in the multi-year Samsung conglomerate discount compression story; acceptance would unlock hidden NAV and strengthen the governance reform narrative that has been a key driver of Korea equity re-rating trades, providing a read-through for activist activity across other Korean chaebol holding structures.
Archive
- Thu Aug 27, 2026 · PM →
- Wed Aug 26, 2026 · PM →
- Wed Aug 26, 2026 · AM →
- Tue Aug 25, 2026 · PM →
- Tue Aug 25, 2026 · AM →
- Mon Aug 24, 2026 · PM →
- Mon Aug 24, 2026 · AM →
- Sun Aug 23, 2026 · AM →
- Fri Aug 21, 2026 · PM →
- Thu Aug 20, 2026 · PM →
- Thu Aug 20, 2026 · AM →
- Wed Aug 19, 2026 · PM →
- Wed Aug 19, 2026 · AM →
- Tue Aug 18, 2026 · PM →
- Tue Aug 18, 2026 · AM →
- Mon Aug 17, 2026 · PM →
- Mon Aug 17, 2026 · AM →
- Sun Aug 16, 2026 · AM →
- Fri Aug 14, 2026 · PM →
- Thu Aug 13, 2026 · PM →
- Thu Aug 13, 2026 · AM →
- Wed Aug 12, 2026 · PM →
- Wed Aug 12, 2026 · AM →
- Tue Aug 11, 2026 · PM →
- Tue Aug 11, 2026 · AM →
- Mon Aug 10, 2026 · PM →
- Mon Aug 10, 2026 · AM →
- Sun Aug 09, 2026 · AM →
- Fri Aug 07, 2026 · PM →
- Thu Aug 06, 2026 · PM →
- Thu Aug 06, 2026 · AM →
- Wed Aug 05, 2026 · PM →
- Wed Aug 05, 2026 · AM →
- Tue Aug 04, 2026 · PM →
- Tue Aug 04, 2026 · AM →
- Mon Aug 03, 2026 · PM →
- Mon Aug 03, 2026 · AM →
- Sun Aug 02, 2026 · AM →
- Fri Jul 31, 2026 · PM →
- Thu Jul 30, 2026 · PM →
- Thu Jul 30, 2026 · AM →
- Wed Jul 29, 2026 · PM →
- Wed Jul 29, 2026 · AM →
- Tue Jul 28, 2026 · PM →
- Tue Jul 28, 2026 · AM →
- Mon Jul 27, 2026 · PM →
- Mon Jul 27, 2026 · AM →
- Sun Jul 26, 2026 · AM →
- Fri Jul 24, 2026 · PM →
- Thu Jul 23, 2026 · PM →
- Thu Jul 23, 2026 · AM →
- Wed Jul 22, 2026 · PM →
- Wed Jul 22, 2026 · AM →
- Tue Jul 21, 2026 · PM →
- Tue Jul 21, 2026 · AM →
- Mon Jul 20, 2026 · PM →
- Mon Jul 20, 2026 · AM →
- Sun Jul 19, 2026 · AM →
- Fri Jul 17, 2026 · PM →
- Thu Jul 16, 2026 · PM →
- Thu Jul 16, 2026 · AM →
- Wed Jul 15, 2026 · PM →
- Wed Jul 15, 2026 · AM →
- Tue Jul 14, 2026 · PM →
- Tue Jul 14, 2026 · AM →
- Mon Jul 13, 2026 · PM →
- Sun Jul 12, 2026 · AM →
- Fri Jul 10, 2026 · PM →
- Thu Jul 09, 2026 · AM →
- Wed Jul 08, 2026 · PM →
- Wed Jul 08, 2026 · AM →
- Tue Jul 07, 2026 · PM →
- Tue Jul 07, 2026 · AM →
- Mon Jul 06, 2026 · PM →
- Mon Jul 06, 2026 · AM →
- Sun Jul 05, 2026 · AM →
- Fri Jul 03, 2026 · PM →
- Thu Jul 02, 2026 · PM →
- Thu Jul 02, 2026 · AM →
- Wed Jul 01, 2026 · PM →
- Wed Jul 01, 2026 · AM →
- Tue Jun 23, 2026 · AM →
- Mon Jun 22, 2026 · PM →
- Mon Jun 22, 2026 · AM →
- Fri Jun 19, 2026 · PM →
- Fri Jun 19, 2026 · AM →
- Thu Jun 18, 2026 · PM →
- Thu Jun 18, 2026 · AM →
- Wed Jun 17, 2026 · PM →
- Wed Jun 17, 2026 · AM →
- Tue Jun 16, 2026 · PM →
- Tue Jun 16, 2026 · AM →
- Mon Jun 15, 2026 · PM →
- Mon Jun 15, 2026 · AM →
- Fri Jun 12, 2026 · PM →
- Fri Jun 12, 2026 · AM →
- Thu Jun 11, 2026 · PM →
- Thu Jun 11, 2026 · AM →
- Wed Jun 10, 2026 · PM →
- Wed Jun 10, 2026 · AM →
- Tue Jun 09, 2026 · PM →
- Tue Jun 09, 2026 · AM →
- Mon Jun 08, 2026 · PM →
- Mon Jun 08, 2026 · AM →
- Fri Jun 05, 2026 · PM →
- Fri Jun 05, 2026 · AM →
- Thu Jun 04, 2026 · PM →
- Thu Jun 04, 2026 · AM →
- Wed Jun 03, 2026 · PM →
- Wed Jun 03, 2026 · AM →
- Tue Jun 02, 2026 · PM →
- Tue Jun 02, 2026 · AM →
- Mon Jun 01, 2026 · PM →
- Mon Jun 01, 2026 · AM →
- Fri May 29, 2026 · PM →
- Fri May 29, 2026 · AM →
- Thu May 28, 2026 · PM →
- Thu May 28, 2026 · AM →
- Wed May 27, 2026 · PM →
- Wed May 27, 2026 · AM →
- Tue May 26, 2026 · PM →
- Tue May 26, 2026 · AM →
- Mon May 25, 2026 · PM →
- Mon May 25, 2026 · AM →
- Fri May 22, 2026 · PM →
- Fri May 22, 2026 · AM →
- Thu May 21, 2026 · PM →
- Thu May 21, 2026 · AM →
- Wed May 20, 2026 · PM →
- Wed May 20, 2026 · AM →
- Tue May 19, 2026 · PM →
- Tue May 19, 2026 · AM →
- Mon May 18, 2026 · AM →
- Fri May 15, 2026 · PM →
- Thu May 14, 2026 · PM →
- Wed May 13, 2026 · PM →
- Tue May 12, 2026 · PM →
- Mon May 11, 2026 · PM →
- Mon May 11, 2026 · AM →
- Fri May 08, 2026 · PM →
- Fri May 08, 2026 · AM →
- Thu May 07, 2026 · PM →
- Thu May 07, 2026 · AM →
- Wed May 06, 2026 · PM →
- Wed May 06, 2026 · AM →
- Tue May 05, 2026 · PM →
- Tue May 05, 2026 · AM →
- Mon May 04, 2026 · PM →
- Mon May 04, 2026 · AM →